RZLT

Rezolute (RZLT)

About Rezolute (RZLT)

Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. The firm's antibody therapy, ersodetug, is designed to treat all forms of hyperinsulinism. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada in March 2010 and is headquartered in Redwood City, CA.

Details

Daily high

$2.12

Daily low

$1.62

Price at open

52 Week High

$11.46

52 Week Low

$1.07

Market cap

187.3M

Dividend yield

0.00%

Volume

19,810

Avg. volume

12.0M

P/E ratio

-2.17

Rezolute News